Assisted Reproduction Technology Devices Market is Expected to Experience a Swift Development by 2026

Assisted reproduction technology (ART) devices have been designed and developed to solve issues pertaining to fertility. Ever since the initial introduction of IVF (in-vitro fertilization) in 1978, technique to resolve pregnancy related issues have come a long way. The advent of assisted reproductive technology offer solutions such as in-vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), intracytoplasmic sperm injection (ICSI), zygote intrafallopian transfer (ZIFT), intrauterine insemination (IUI), and surrogacy. The Centers for Disease Control and Prevention (CDC) states that 208,604 ART cycles were conducted at 458 clinics in the U.S., of which 57,323 were live births and 70,354 were live born infants in 2014. Though the usage of ART is not significant, its demand has still soared in the recent past.

The research report by Transparency Market Research provides a comprehensive outlook of the global Assisted Reproduction Technology Devices Market. The publication is aimed at providing a detailed analysis of the segments in the market, the competitive landscape, financial outlook of the companies operating in the market, and the supply chain analysis.

The global assisted reproduction technology devices market is expected to witness a significant boost in the coming years due to the growing support by governments for research and development. The rise in funding for developing efficient and safe assisted reproduction technology devices is expected to make a positive impact on the global market.

The high prevalence of male and female infertility due to poor lifestyle choices, deferred pregnancies, and health conditions have collectively boosted the demand for assisted reproduction technology devices. Infertility in males is observed due to poor sperm count, blocked sperm ducts, and poor sperm movement. On the other hand, female infertility is usually a result of dysfunctional fallopian tubes along with issues related to cervix or uterus.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14330

The growth of medical tourism and the possibility of surrogacy in emerging economies has been crucial to the growth of this market in recent years. The high cost of using these technologies and devices in developed countries has dissuaded several patients and made them migrate to developing countries, where seeking medical treatment is relatively cheaper.